Christine Schmahl and Svenja Taubner are initiating a BPD research study to evaluate the effects of treatment with MDMA (ecstasy) and Mentalization Based Therapy on people with BPD. This is the first BPD study ever of psychedlics along with MBT. Dr. Taubner: Institute for Psychosocial Prevention, University Heidelber DR Schmahl: Dept. of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Mannheim